Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne-Reference-Cited by-同舟云学术

Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne

Published:2024-05-01 Issue:5 Volume:47 Page:930-940
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Murae Mana¹²,Sakai Shota¹,Miyata Non¹,Shimizu Yoshimi¹³,Okemoto-Nakamura Yuko¹,Kishimoto Takuma⁴,Ogawa Motohiko⁵,Tani Hideki⁶,Tanaka Kazuma⁴,Noguchi Kohji²,Fukasawa Masayoshi¹²

Affiliation:

1. Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases

2. Laboratory of Molecular Targeted Therapy, Faculty of Pharmaceutical Sciences, Tokyo University of Science

3. Department of Pharmaceutical Sciences, Teikyo Heisei University

4. Division of Molecular Interaction, Institute for Genetic Medicine, Hokkaido University Graduate School of Life Science

5. Department of Virology I, National Institute of Infectious Diseases

6. Department of Virology, Toyama Institute of Health

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/5/47_b23-00797/_pdf

Reference30 articles.

1. 1) Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269 (2020).

2. 2) Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 395, 689–697 (2020).

3. 3) Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis., 91, 264–266 (2020).

4. 4) Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395, 507–513 (2020).

5. 5) Bonaventura A, Vecchie A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol., 21, 319–329 (2021).